Does ROSUVASTATIN Cause Chronic obstructive pulmonary disease? 474 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 474 reports of Chronic obstructive pulmonary disease have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 1.3% of all adverse event reports for ROSUVASTATIN.
474
Reports of Chronic obstructive pulmonary disease with ROSUVASTATIN
1.3%
of all ROSUVASTATIN reports
17
Deaths
294
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From ROSUVASTATIN?
Of the 474 reports, 17 (3.6%) resulted in death, 294 (62.0%) required hospitalization, and 18 (3.8%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 474 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which ROSUVASTATIN Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN